NCT07717866Active, not recruiting
Trifecta Research Study
Trifecta Research Study - An Observational Study Evaluating the Impact of Ibogaine-Magnesium, 5-MeO-DMT, Magnetic e-Resonance Therapy, and Physiological Supplementation in Special Operations Forces Combat Veterans
Source: ClinicalTrials.gov · Last updated 21 Jul 2026
Brief summary (registry, in English)
This observational study evaluates the impact of Ibogaine-Magnesium (IM), 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT), Magnetic e-Resonance Therapy (MeRT), and Physiological Supplementation (PS) on posttraumatic stress disorder (PTSD) and traumatic brain injury-related cognitive symptoms among Special Operations Forces (SOF) combat veterans.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 52 (actual)
- First submitted
- 16 Jul 2026
- Start date
- 1 Aug 2022
- Primary completion date
- 1 Feb 2026
- Lead sponsor
- Axial Therapeutic Research
- Diseases
- Depression
- NCT number
- NCT07717866
What you commit to
- Study type: Observational
- Participants enrolled: 52
- From 1 Aug 2022 to the primary completion date, 1 Feb 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Refusal to taper off of selective serotonin reuptake inhibitor (SSRI) medication
Other illness
- Diagnosis of Schizophrenia, Bipolar I or II disorder for which patient has been hospitalized or medicated, Depersonalization and/or Derealization Disorder
- Cerebellar dysfunction, Epilepsy, Psychosis or acute confusional state, Dementia
- History of heart failure or hypertrophic heart
- Active blood clots (e.g., Pulmonary embolism, Deep vein thrombosis)
- Major respiratory conditions (e.g., Emphysema, Cystic fibrosis)
- Severe chronic gastrointestinal issues (e.g., bleeding ulcer, leaky gut syndrome)
Lab values
- Prolonged corrected QT interval (QTc) Interval (450ms in males; 470ms in females)
- Abnormal blood test results (e.g., potassium or magnesium outside normal range)
Other
- Within 6 months of surgeries
- Impaired kidney or liver function
Who the study is looking for
- At least 18 years of age
- Sponsored by SOC-F Program
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Axial Therapeutic Research Coordinator of this site? Confirm its status | Northridge | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.